HighTower Advisors’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
Other funds holding DARE
VF
HighTower Advisors's DARE Position: Q4 2025 in Review
HighTower Advisors sold out of Dare Bioscience (DARE) in Q4 2025, closing a stake of 11,692 shares — an estimated $24.6K sold.
HighTower Advisors first reported a position in DARE in Q1 2020 and held it in 18 quarters. The position peaked at $76K in Q2 2022. 27 funds tracked by Wall St. Rank hold DARE as of Q4 2025.
- HighTower Advisors reported no remaining Dare Bioscience position as of Q4 2025 after selling out during the quarter.
- HighTower Advisors sold 11,692 Dare Bioscience shares in Q4 2025, an estimated $24.6K.
- HighTower Advisors first reported a position in Dare Bioscience in Q1 2020 and held it in 18 quarters.
- HighTower Advisors's Dare Bioscience position peaked at $76K in Q2 2022.
- 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2025.
Based on HighTower Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.